Infinity Pharma teams up with AbbVie for cancer drug

Now watching

Next video starts in : 7 Play

Infinity Pharma teams up with AbbVie for cancer drug

Infinity Pharma teams up with AbbVie for cancer drug
Replay video
Up next

If China falls,buy this stock

Unlock your personal NFL Now stream by signing in to NFL.com

Infinity Pharma teams up with AbbVie for cancer drug

by CNBC Videos 1:41 mins

Infinity Pharma will receive $275 million upfront from AbbVie, as part of a new venture to develop blood cancer treatments. Infinity CEO Adelene Q. Perkins, explains the significance of the deal, with CNBC's Meg Tirrell.

View Comments (0)